AstraZeneca R&D: Turning science into medicine

Introducing AstraZeneca R&D

We are driven by science, united by science, and every day, we push the boundaries of science to deliver life-changing medicines.

What science can do

We are never complacent about scientific discovery and development, always pushing our R&D productivity, searching for new knowledge and the next breakthrough.

Read about our approach to R&D

Transforming our science

Guided by our ‘Growth Through Innovation’ strategy, we are committed to investing in four areas, which will help us in our aspiration to create the greatest and swiftest impact on disease.

Learn more about our transformative science

Our people are our power

Our business and scientific culture is diverse, inclusive and collaborative, and we do everything in our power to enable all our people to be the best they can be.

Qing-Dong Wang

Senior Principal Scientist, Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Slavé Petrovski

VP, Head of Centre for Genomics Research, Discovery Sciences, R&D

Malin Lemurell

Executive Director and Head of Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D

Meet more of our people

Oncology

Cardiovascular, Renal & Metabolism

Respiratory & Immunology

Vaccines & Immune Therapies

Neuroscience

Alexion Rare Diseases

Scientific capabilities

Our unique scientific capabilities enable us to deliver what we believe to be one of the most productive pipelines in the industry.

We have built and invested in cutting-edge technologies to enable us to fast-forward the pace of our science, helping us achieve the next wave of breakthroughs and do things that have never been done before.

In our quest to transform disease, we believe it is essential to target novel biology we uncover. We are continuing to design new ways to target the drivers of disease to help us create the next generation of therapeutics.

Data Science and AI have the potential to transform the way we discover and develop new medicines. We hope to be able to increase the probability of success and reduce timelines in our drug discovery and development process by applying advanced AI and machine learning across R&D.